John Duan

Neurology Therapeutic Area Lead, Global Marketing at Alexion Pharmaceuticals, Inc.

John Duan is the Neurology Therapeutic Area Lead for Global Marketing at Alexion Pharmaceuticals, Inc., a position he has held since October 2021. He has over 15 years of experience in the pharmaceutical and biotech industries, focusing on global strategic marketing, new product planning, commercial evaluation, forecasting, and marketing research.

Professional Background

Current Role: Neurology Therapeutic Area Lead, Global Marketing at Alexion Pharmaceuticals, Inc. (October 2021 - Present)
Previous Positions:
- Senior Director, Neurology Emerging Indications, Global Marketing at Alexion Pharmaceuticals (July 2020 - October 2021)
- Global Commercial Lead at Takeda (June 2015 - July 2020)
- Head of Global Commercial Analysis at Astellas Pharma US (2012 - 2015)
- Director of Latuda Commercial Insights and Analytics at Dainippon Sumitomo Pharma (2009 - 2011)
- Director of Commercial Assessment at Savient Pharmaceuticals (2007 - 2009)
- Global New Product role at Bayer Pharmaceuticals (2000 - 2007)

Education

John holds an MBA in Finance from NYU Stern School of Business, which he completed from 1997 to 2000.

John is recognized for his detail-oriented and pragmatic approach to pharmaceutical market analysis, reflecting his extensive expertise in the field.1

Experience

Neurology Therapeutic Area Lead, Global Marketing at Alexion Pharmaceuticals, Inc. (October 2021 - Present)

Senior Director, Neurology Emerging Indications, Global Marketing at Alexion Pharmaceuticals, Inc. (July 2020 - October 2021); Global Commercial Lead at Takeda (June 2015 - July 2020); Head, Global Commercial Analysis at Astellas Pharma US (2012 - 2015); Director, Latuda Commercial Insights and Analytics at Dainippon Sumitomo Pharma (2009 - 2011); Director, Commercial Assessment at Savient Pharmaceuticals, Inc. (2007 - 2009); Global New Product at Bayer Pharmaceuticals (2000 - 2007)